LA Billionaire's Biotech Firm Inks With Alexandria

Alexandria Real Estate Equities strikes again. This time, in the former Novartis space in its Nautilus campus.

NantKwest Inc inked a deal for 44,700 SF at 3530 John Hopkins Ct, part of the complex once used by Merck & Co and Novartis, according to filings with the SEC. Alexandria, which bought the Nautilus project in 2012 and renovated into a life science complex, inked the sizable deal with NantKwest this past summer for both office and R&D uses, according to docs.

This deal is part of what Alexandria's Dan Ryan recently called the best leasing quarter in 20 years. The firm also secured a build-to-suit with Eli Lilly at its Campus Point Drive project. This deal for NantKwest comes on the heels of that biotech's recent IPO, which secured a market cap of more than $2B. NantKwest, controlled by LA billionaire Patrick Soon-Shiong (here), makes cancer immunotherapy medicines.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's San Diego Newsletters
Related Stories

Why Top-Secret Facilities Are Permeating Greater D.C.'s Office Market

DivcoWest Sells Glendale Office Building For $70M

Hines And Rialto Close Office Credit Fund At $1.1B

Rig Collapse At Citadel HQ Site Sends 4 To Hospital

Northern Virginia Office Tower Sells For Double Its 2024 Price

Oxford Properties' U.S. Investment Head On Why It's Buying Office Again — And Where

Fertility Provider Opens Clinic At 1900 Lawrence Office Tower: The Denver Deal Sheet

Office Revenues Are Failing To Keep Pace With Expenses

Security Tech Firm Plans Loudoun HQ Move: The D.C. Deal Sheet

Stephen Ross Expands Palm Beach Empire With Massive Boca Raton Campus

25 Years After 9/11, Lower Manhattan Is Finally Firing On All Cylinders

Tishman Speyer Seeks $92M Tax Break For Next Hudson Yards Office Tower